|
|
|
Insider
Information: |
Lange Louis G |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
582,756 |
|
Indirect Shares
|
228,940 |
|
|
Direct
Value |
$83,307 |
|
|
Indirect Value
|
$403,314 |
|
|
Total
Shares |
811,696 |
|
|
Total
Value |
$486,621 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
CV Therapeutics Inc |
CVTX |
Chairman & CEO, Director |
2009-04-09 |
483,618 |
2009-04-09 |
6,359 |
Premium* |
|
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
60,000 |
2009-09-22 |
0 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2013-07-01 |
17,814 |
2013-07-01 |
197,703 |
Premium* |
|
Cymabay Therapeutics, Inc. |
CBAY |
Director |
2013-10-11 |
1,446 |
|
0 |
Premium* |
|
Audentes Therapeutics, Inc. |
BOLD |
Director |
2020-01-15 |
0 |
2020-01-15 |
0 |
Premium* |
|
Newamsterdam Pharma Ord Shs |
NAMS |
|
2023-12-29 |
19,878 |
2024-02-13 |
24,878 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
99 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CBAY |
Cymabay Therapeutics, Inc... |
Director |
|
2013-10-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,446 |
|
- |
|
BOLD |
Audentes Therapeutics, In... |
Director |
|
2016-07-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
120,501 |
|
- |
|
BOLD |
Audentes Therapeutics, In... |
Director |
|
2016-07-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
466,799 |
|
- |
|
NAMS |
Newamsterdam Pharma Ord S... |
|
|
2023-12-29 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
19,878 |
|
- |
|
NAMS |
Newamsterdam Pharma Ord S... |
|
|
2023-12-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,878 |
|
- |
|
CVTX |
CV Therapeutics Inc |
officerTitle |
|
2006-01-03 |
4 |
D |
$24.76 |
$2,971 |
D/D |
(120) |
107,360 |
|
- |
|
CVTX |
CV Therapeutics Inc |
officerTitle |
|
2006-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
282 |
107,480 |
|
- |
|
CVTX |
CV Therapeutics Inc |
Chairman & CEO |
|
2009-01-15 |
4 |
D |
$9.33 |
$2,668 |
D/D |
(286) |
305,630 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
Chairman & CEO |
|
2007-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
292 |
173,652 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
Chairman & CEO |
|
2008-01-10 |
4 |
D |
$8.93 |
$3,197 |
D/D |
(358) |
251,688 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
Chairman & CEO |
|
2004-05-20 |
4 |
OE |
$9.25 |
$4,625 |
D/D |
500 |
105,273 |
|
- |
|
CVTX |
CV Therapeutics Inc |
Chairman and CEO |
|
2004-01-13 |
4 |
A |
$14.67 |
$10,000 |
I/I |
682 |
1,153 |
|
- |
|
CVTX |
CV Therapeutics Inc |
Chairman & CEO |
|
2007-08-17 |
4 |
A |
$8.55 |
$6,549 |
D/D |
766 |
209,274 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
Chairman & CEO |
|
2009-01-15 |
4 |
OE |
$9.33 |
$7,473 |
D/D |
801 |
305,916 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
Chairman & CEO |
|
2008-01-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
837 |
252,046 |
0 |
- |
|
BOLD |
Audentes Therapeutics, In... |
Director |
|
2019-06-24 |
4 |
AS |
$37.89 |
$38,201 |
I/I |
(1,000) |
15,678 |
0 |
- |
|
BOLD |
Audentes Therapeutics, In... |
Director |
|
2019-09-23 |
4 |
AS |
$32.18 |
$32,182 |
I/I |
(1,000) |
14,678 |
0 |
- |
|
BOLD |
Audentes Therapeutics, In... |
Director |
|
2019-12-23 |
4 |
AS |
$59.60 |
$59,596 |
I/I |
(1,000) |
13,678 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
Chairman & CEO |
|
2007-05-17 |
4 |
A |
$8.55 |
$9,243 |
D/D |
1,081 |
202,188 |
0 |
- |
|
BOLD |
Audentes Therapeutics, In... |
Director |
|
2019-03-25 |
4 |
AS |
$35.94 |
$56,058 |
I/I |
(1,558) |
0 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
Chairman and CEO |
|
2003-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,900 |
103,284 |
|
- |
|
BOLD |
Audentes Therapeutics, In... |
Director |
|
2017-09-25 |
4 |
AS |
$27.99 |
$85,055 |
I/I |
(3,000) |
7,558 |
0 |
- |
|
BOLD |
Audentes Therapeutics, In... |
Director |
|
2017-12-22 |
4 |
AS |
$30.86 |
$92,633 |
I/I |
(3,000) |
4,558 |
0 |
- |
|
ESPR |
Esperion Therapeutics, In... |
Director |
|
2013-07-01 |
4 |
B |
$14.00 |
$49,000 |
D/D |
3,500 |
17,814 |
2.39 |
- |
|
CVTX |
CV Therapeutics Inc |
Chairman & CEO |
|
2007-03-22 |
4 |
D |
$8.80 |
$34,232 |
D/D |
(3,890) |
201,107 |
0 |
- |
|
99 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|